SCHEMBL6568629

SCHEMBL6568629

COc1ccc(NC(=O)NC(C)(C)C)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 2/20 0.58
IMPDH1 P20839 2/20 0.58
TRPV1 Q8NER1 1/20 0.53
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
ALDH1A1 P00352 3/20 0.52
TP53 P04637 3/20 0.52
GAA P10253 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.52
KDM4E B2RXH2 3/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 1/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 2/20 0.48
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566909 0.85 KMT2A (0.51) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL6567640 0.84 HTT (0.65) IMPDH2IMPDH1KMT2AMEN1NPC1
SCHEMBL5726240 0.79 SMN1; SMN2 (0.63) TRPV1KMT2AMEN1NPC1RAB9A
SCHEMBL4689726 0.79 ALDH1A1 (0.58) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL7284429 0.79 TUBB4A (0.59) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL3041887 0.79 ALDH1A1 (0.58) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL5692466 0.78 SMN1; SMN2 (0.57) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL12403816 0.77 TUBB1 (0.49) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL9823917 0.77 CYP1A2 (0.77) IMPDH2IMPDH1TRPV1KMT2AMEN1
SCHEMBL13756247 0.76 RAB9A (0.81) TRPV1KMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed